Titers read and immunity resolved.
Lab results read and interpreted against facility rules — immune, equivocal, or non-immune — with the follow-up path handled.
What it is
Titer results aren't binary: equivocal results, facility-specific cutoffs, and booster-versus-retest decisions trip up onboarding constantly. The agents read the lab report, apply the facility's acceptance rules, and when a result is non-immune, initiate the right follow-up — booster series or repeat draw — without a specialist untangling it.
How the agents run it · Health & Clinical Readiness
01
Read
Quantitative results are extracted from the lab report.
02
Interpret
Values are checked against the facility's immunity criteria — including equivocal handling.
03
Route
Non-immune results trigger the facility's follow-up path: booster, series, or declination process.
04
Track
Multi-step follow-ups (like a Hep B series) are tracked across their full timeline.
What you get
- Equivocal results handled by rule, not guesswork
- Booster series tracked across weeks without dropping
- Facility cutoffs applied consistently
Questions
What happens when a titer comes back non-immune?
The agent applies the facility's rule — typically initiating a booster or vaccine series and scheduling the follow-up draw — and tracks the multi-week process to completion.
Which titers do facilities usually require?
Most commonly MMR (measles, mumps, rubella), varicella, and Hepatitis B surface antibody. The agents handle whichever the facility's matrix specifies, at its cutoff values.
More in Health & Clinical Readiness
See titers run live.
Thirty minutes, one placement, worked live — start to submit-ready.